(Total Views: 533)
Posted On: 03/03/2021 2:03:58 PM
Post# of 72447
The article linked below has the following paragraph.
“On February 9, 2021, the journal Cell Culture published a paper that concluded Brilacidin was shown to exert potent inhibitory effects on SARS-CoV-2 in cell culture by decreasing viral load in different cell types, including ACE2 positive human lung cells, and, importantly, in both the Washington and Italian strains of the coronavirus. Testing of Brilacidin against additional SARS-CoV-2 strains is planned, concluded this paper.”
https://www.precisionvaccinations.com/vaccine...herapeutic
Is this paragraph referring to the pre-print of the peer reviewed article that appeared in the journal Viruses? I don’t recall seeing anything previously about the journal “Cell Culture”.
“On February 9, 2021, the journal Cell Culture published a paper that concluded Brilacidin was shown to exert potent inhibitory effects on SARS-CoV-2 in cell culture by decreasing viral load in different cell types, including ACE2 positive human lung cells, and, importantly, in both the Washington and Italian strains of the coronavirus. Testing of Brilacidin against additional SARS-CoV-2 strains is planned, concluded this paper.”
https://www.precisionvaccinations.com/vaccine...herapeutic
Is this paragraph referring to the pre-print of the peer reviewed article that appeared in the journal Viruses? I don’t recall seeing anything previously about the journal “Cell Culture”.
(3)
(2)
